This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Greiner RA, Azoulay M, Brandle M.Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 and type 2 diabetes in Switzerland. 20th World Diabetes Congress: abstr. P-1595, 18 Oct 2009. Available from: URL: http://www.worlddiabetescongress.org/
Aagren M.Long term cost-effectiveness of insulin detemir versus insulin glargine in type 2 diabetes patients: an analysis based on real life clinical data from a US managed care setting. 20th World Diabetes Congress: abstr. P-1597, 18 Oct 2009. Available from: URL: http://www.worlddiabetescongress.org/
Rights and permissions
About this article
Cite this article
Insulin glargine dually compared. Pharmacoecon. Outcomes News 591, 12 (2009). https://doi.org/10.2165/00151234-200905910-00027
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905910-00027